查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566756

免疫检测市场：按产品、技术、检体和最终用户分类：2024-2033 年全球机会分析和产业预测

Immunoassay Market By Product, By Technology By Specimen By End user : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 216 Pages | 商品交期: 2-3个工作天内

价格
简介目录

免疫检测市场

2023年免疫检测市值为350亿美元，预计2024年至2033年复合年增长率为5.8%，到2033年达到616亿美元。

免疫检测是一种生物分析方法，可检测和定量样本中蛋白质和抗原的存在。免疫检测的基本原理依赖抗体与目标分子的相互作用，产生可量化的讯号，例如萤光或颜色变化。此方法可应用于药物研究、医学诊断和环境监测。该方法的高特异性和敏感性对于监测药物水平、诊断疾病、筛检传染源和检测生物标记至关重要。

感染疾病和慢性病的增加是免疫检测市场的关键驱动因素。此外，对製药和生物技术基础设施的快速投资正在导致基础设施扩张，推动对临床试验、生物标记分析和药物发现等多种用途的免疫检测组件的需求。免疫检测市场的趋势不断发展，提高了测试的敏感度和特异性。机器人技术和自动化的整合在市场上越来越受欢迎，因为它有助于提高生产力并减少测试实验室的人为错误。

然而，采购可靠的设备和真实的样品对于取得良好的结果至关重要。由于行业中零售商稀缺，此类可靠组件的可用性是一项挑战，限制了免疫检测市场的开拓。同时，免疫检测系统製造商也正在努力推出创新产品，为市场开拓创造了机会。预计下一代免疫检测系统将利用微射流和奈米技术的优势来提供即时、准确的结果。

按部门审查

免疫检测市场分为产品、技术、检体、最终用户和地区。依产品划分，市场分为试剂/试剂套件和分析仪器。依技术分为ELISA、化学冷光免疫检测、免疫萤光法、快速诊断法、ELISpot、 西方印渍术等。依检体，可分为感染疾病、内分泌学、肿瘤学、骨矿物质疾病、循环系统、血液筛检、自体免疫疾病、过敏诊断、毒理学、新生儿筛检等。最终使用者分为医院/诊所、临床实验室、製药/生技公司、血库、研究/学术实验室和居家医疗环境。从区域来看，分析包括北美、欧洲、亚太地区和拉丁美洲/中东/非洲。

主要发现

依技术划分，ELISA 细分市场 2023 年收益最高。

以检体来看，血液筛检板块于2023年成为第一大股东。

按最终用户划分，医院和诊所细分市场将在 2023 年获得较高的市场占有率。

按地区划分，北美地区 2023 年收益最高。

该报告可以定制（需要单独的费用和时间表）。

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 扩大公司简介列表
  • 历史市场资料

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 关键投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章免疫检测市场：副产品

  • 市场概况
  • 试剂和套件
  • 分析仪

第五章免疫检测市场：依技术分类

  • 市场概况
  • 酵素连结免疫吸附法
  • 化学冷光免疫检测
  • 萤光免疫分析
  • 快速诊断
  • 酵素连结免疫斑点法
  • 西方印渍术
  • 其他的

第 6 章免疫检测：依市场检体

  • 市场概况
  • 感染疾病
  • 内分泌学
  • 肿瘤学
  • 骨骼/矿物质疾病
  • 心臟病学
  • 验血
  • 自体免疫疾病
  • 过敏诊断
  • 毒理学
  • 新生儿筛检
  • 其他的

第七章免疫检测市场：依最终用户分类

  • 市场概况
  • 医院/诊所
  • 临床研究所
  • 製药和生物技术公司
  • 血库
  • 研究与学术机构
  • 居家医疗

第八章免疫检测市场：按地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国免疫检测市场
    • 加拿大免疫检测市场
    • 墨西哥免疫检测市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国免疫检测市场
    • 德国免疫检测市场
    • 义大利免疫检测市场
    • 西班牙免疫检测市场
    • 英国免疫检测市场
    • 其他欧洲免疫检测市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国免疫检测市场
    • 日本免疫检测市场
    • 印度免疫检测市场
    • 韩国免疫检测市场
    • 澳洲免疫检测市场
    • 其他亚太免疫检测市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西免疫检测市场
    • 南非免疫检测市场
    • 沙乌地阿拉伯免疫检测市场
    • 其他拉丁美洲/中东/非洲免疫检测市场

第9章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 有竞争力的仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第十章 公司简介

  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Abbott Laboratories
  • Siemens Healthineers
  • DiaSorin SpA
  • Sysmex Corporation
  • BioMerieux SA
  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson And Company
  • Merck KGaA
简介目录
Product Code: A00792

Immunoassay Market

The immunoassay market was valued at $35.0 billion in 2023 and is projected to reach $61.6 billion by 2033, growing at a CAGR of 5.8% from 2024 to 2033.

Immunoassay is a bioanalytical method that detects and quantifies the presence of proteins or antigens in a sample. The basic principle of immunoassay relies on the interaction between an antibody and a target molecule, which results in the generation of a quantifiable signal, such as fluorescence or color change. The method finds applications in pharmaceutical research, medical diagnostics, and environmental monitoring. The high specificity & sensitivity of the method is pivotal in monitoring drug levels, diagnosing diseases, screening for infectious agents, and detecting biomarkers.

Rise in the prevalence of infectious and chronic diseases is a significant driver of the immunoassay market. In addition, surge in investments in the pharmaceutical & biotechnology infrastructure has led to the expansion in infrastructure, thereby boosting the demand for immunoassay components for diverse purposes such as clinical trials, biomarker analysis, and drug discovery. Trends in the immunoassay market evolve constantly, enhancing the sensitivity and specificity of the tests. The integration of robotics and automation is acquiring traction in the market as it is enhancing productivity and helping to reduce human error in the laboratories.

However, procuring reliable instruments and authentic samples to critical for obtaining successful results. The acquisition of such trustworthy components is a challenging task owing to less retailers in the industry, thereby restraining the development of the immunoassay market. On the contrary, manufacturers of immunoassay systems strive to introduce innovative products, thereby presenting lucrative opportunities for market development. Next generation of immunoassay systems is projected to leverage the benefits of microfluidics and nanotechnology for achieving instant & accurate results.

Segment Review

The immunoassay market is segmented into product, technology, specimen, end user, and region. On the basis of product, the market is bifurcated into reagents & kits and analyzers. As per technology, it is classified into ELISA, chemiluminescence immunoassay, immunofluorescence assay, rapid test, ELISpot, western blotting, and others. According to specimen, it is categorized into infectious diseases, endocrinology, oncology, bone & mineral disorders, cardiology, blood screening, autoimmune disorders, allergy diagnostics, toxicology, newborn screening, and others. By end user, it is divided into hospitals & clinics, clinical laboratories, pharmaceutical & biotechnology companies, blood banks, research & academic laboratories, and home care settings. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

As per technology, the ELISA segment generated the highest revenue in 2023.

According to specimen, the blood screening segment was the highest shareholder in 2023.

By end user, the hospitals & clinics segment acquired high market stakes in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The major players operating in the global immunoassay market include F. Hoffmann-La Roche Ltd., Danaher Corporation, Abbott Laboratories, Siemens Healthineers, DiaSorin S.p.A., Sysmex Corporation, BioMerieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, and Merck kGaA. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Product

  • Reagents and Kits
  • Analyzers

By Technology

  • ELISA
  • Chemiluminescence Immunoassay
  • Immunofluorescence assay
  • Rapid Test
  • ELISpot
  • Western Blotting
  • Others

By Specimen

  • Infectious Diseases
  • Endocrinology
  • Oncology
  • Bone and Mineral Disorders
  • Cardiology
  • Blood Screening
  • Autoimmune Disorders
  • Allergy Diagnostics
  • Toxicology
  • Newborn Screening
  • Others

By End User

  • Hospitals and Clinics
  • Clinical Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Blood Banks
  • Research and Academic Laboratories
  • Home Care Settings

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • F. Hoffmann-La Roche Ltd.
    • Danaher Corporation
    • Abbott Laboratories
    • Siemens Healthineers
    • DiaSorin S.p.A.
    • Sysmex Corporation
    • BioMerieux SA
    • Ortho Clinical Diagnostics
    • Thermo Fisher Scientific, Inc.
    • Becton, Dickinson and Company
    • Merck kGaA

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: IMMUNOASSAY MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Reagents And Kits
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Analyzers
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: IMMUNOASSAY MARKET, BY TECHNOLOGY

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Technology
  • 5.2. ELISA
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Chemiluminescence Immunoassay
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Immunofluorescence Assay
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Rapid Test
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. ELISpot
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country
  • 5.7. Western Blotting
    • 5.7.1. Key Market Trends, Growth Factors and Opportunities
    • 5.7.2. Market Size and Forecast, By Region
    • 5.7.3. Market Share Analysis, By Country
  • 5.8. Others
    • 5.8.1. Key Market Trends, Growth Factors and Opportunities
    • 5.8.2. Market Size and Forecast, By Region
    • 5.8.3. Market Share Analysis, By Country

CHAPTER 6: IMMUNOASSAY MARKET, BY SPECIMEN

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Specimen
  • 6.2. Infectious Diseases
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Endocrinology
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Oncology
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Bone And Mineral Disorders
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country
  • 6.6. Cardiology
    • 6.6.1. Key Market Trends, Growth Factors and Opportunities
    • 6.6.2. Market Size and Forecast, By Region
    • 6.6.3. Market Share Analysis, By Country
  • 6.7. Blood Screening
    • 6.7.1. Key Market Trends, Growth Factors and Opportunities
    • 6.7.2. Market Size and Forecast, By Region
    • 6.7.3. Market Share Analysis, By Country
  • 6.8. Autoimmune Disorders
    • 6.8.1. Key Market Trends, Growth Factors and Opportunities
    • 6.8.2. Market Size and Forecast, By Region
    • 6.8.3. Market Share Analysis, By Country
  • 6.9. Allergy Diagnostics
    • 6.9.1. Key Market Trends, Growth Factors and Opportunities
    • 6.9.2. Market Size and Forecast, By Region
    • 6.9.3. Market Share Analysis, By Country
  • 6.10. Toxicology
    • 6.10.1. Key Market Trends, Growth Factors and Opportunities
    • 6.10.2. Market Size and Forecast, By Region
    • 6.10.3. Market Share Analysis, By Country
  • 6.11. Newborn Screening
    • 6.11.1. Key Market Trends, Growth Factors and Opportunities
    • 6.11.2. Market Size and Forecast, By Region
    • 6.11.3. Market Share Analysis, By Country
  • 6.12. Others
    • 6.12.1. Key Market Trends, Growth Factors and Opportunities
    • 6.12.2. Market Size and Forecast, By Region
    • 6.12.3. Market Share Analysis, By Country

CHAPTER 7: IMMUNOASSAY MARKET, BY END USER

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By End User
  • 7.2. Hospitals And Clinics
    • 7.2.1. Key Market Trends, Growth Factors and Opportunities
    • 7.2.2. Market Size and Forecast, By Region
    • 7.2.3. Market Share Analysis, By Country
  • 7.3. Clinical Laboratories
    • 7.3.1. Key Market Trends, Growth Factors and Opportunities
    • 7.3.2. Market Size and Forecast, By Region
    • 7.3.3. Market Share Analysis, By Country
  • 7.4. Pharmaceutical And Biotechnology Companies
    • 7.4.1. Key Market Trends, Growth Factors and Opportunities
    • 7.4.2. Market Size and Forecast, By Region
    • 7.4.3. Market Share Analysis, By Country
  • 7.5. Blood Banks
    • 7.5.1. Key Market Trends, Growth Factors and Opportunities
    • 7.5.2. Market Size and Forecast, By Region
    • 7.5.3. Market Share Analysis, By Country
  • 7.6. Research And Academic Laboratories
    • 7.6.1. Key Market Trends, Growth Factors and Opportunities
    • 7.6.2. Market Size and Forecast, By Region
    • 7.6.3. Market Share Analysis, By Country
  • 7.7. Home Care Settings
    • 7.7.1. Key Market Trends, Growth Factors and Opportunities
    • 7.7.2. Market Size and Forecast, By Region
    • 7.7.3. Market Share Analysis, By Country

CHAPTER 8: IMMUNOASSAY MARKET, BY REGION

  • 8.1. Market Overview
    • 8.1.1 Market Size and Forecast, By Region
  • 8.2. North America
    • 8.2.1. Key Market Trends and Opportunities
    • 8.2.2. Market Size and Forecast, By Product
    • 8.2.3. Market Size and Forecast, By Technology
    • 8.2.4. Market Size and Forecast, By Specimen
    • 8.2.5. Market Size and Forecast, By End User
    • 8.2.6. Market Size and Forecast, By Country
    • 8.2.7. U.S. Immunoassay Market
      • 8.2.7.1. Market Size and Forecast, By Product
      • 8.2.7.2. Market Size and Forecast, By Technology
      • 8.2.7.3. Market Size and Forecast, By Specimen
      • 8.2.7.4. Market Size and Forecast, By End User
    • 8.2.8. Canada Immunoassay Market
      • 8.2.8.1. Market Size and Forecast, By Product
      • 8.2.8.2. Market Size and Forecast, By Technology
      • 8.2.8.3. Market Size and Forecast, By Specimen
      • 8.2.8.4. Market Size and Forecast, By End User
    • 8.2.9. Mexico Immunoassay Market
      • 8.2.9.1. Market Size and Forecast, By Product
      • 8.2.9.2. Market Size and Forecast, By Technology
      • 8.2.9.3. Market Size and Forecast, By Specimen
      • 8.2.9.4. Market Size and Forecast, By End User
  • 8.3. Europe
    • 8.3.1. Key Market Trends and Opportunities
    • 8.3.2. Market Size and Forecast, By Product
    • 8.3.3. Market Size and Forecast, By Technology
    • 8.3.4. Market Size and Forecast, By Specimen
    • 8.3.5. Market Size and Forecast, By End User
    • 8.3.6. Market Size and Forecast, By Country
    • 8.3.7. France Immunoassay Market
      • 8.3.7.1. Market Size and Forecast, By Product
      • 8.3.7.2. Market Size and Forecast, By Technology
      • 8.3.7.3. Market Size and Forecast, By Specimen
      • 8.3.7.4. Market Size and Forecast, By End User
    • 8.3.8. Germany Immunoassay Market
      • 8.3.8.1. Market Size and Forecast, By Product
      • 8.3.8.2. Market Size and Forecast, By Technology
      • 8.3.8.3. Market Size and Forecast, By Specimen
      • 8.3.8.4. Market Size and Forecast, By End User
    • 8.3.9. Italy Immunoassay Market
      • 8.3.9.1. Market Size and Forecast, By Product
      • 8.3.9.2. Market Size and Forecast, By Technology
      • 8.3.9.3. Market Size and Forecast, By Specimen
      • 8.3.9.4. Market Size and Forecast, By End User
    • 8.3.10. Spain Immunoassay Market
      • 8.3.10.1. Market Size and Forecast, By Product
      • 8.3.10.2. Market Size and Forecast, By Technology
      • 8.3.10.3. Market Size and Forecast, By Specimen
      • 8.3.10.4. Market Size and Forecast, By End User
    • 8.3.11. UK Immunoassay Market
      • 8.3.11.1. Market Size and Forecast, By Product
      • 8.3.11.2. Market Size and Forecast, By Technology
      • 8.3.11.3. Market Size and Forecast, By Specimen
      • 8.3.11.4. Market Size and Forecast, By End User
    • 8.3.12. Rest of Europe Immunoassay Market
      • 8.3.12.1. Market Size and Forecast, By Product
      • 8.3.12.2. Market Size and Forecast, By Technology
      • 8.3.12.3. Market Size and Forecast, By Specimen
      • 8.3.12.4. Market Size and Forecast, By End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key Market Trends and Opportunities
    • 8.4.2. Market Size and Forecast, By Product
    • 8.4.3. Market Size and Forecast, By Technology
    • 8.4.4. Market Size and Forecast, By Specimen
    • 8.4.5. Market Size and Forecast, By End User
    • 8.4.6. Market Size and Forecast, By Country
    • 8.4.7. China Immunoassay Market
      • 8.4.7.1. Market Size and Forecast, By Product
      • 8.4.7.2. Market Size and Forecast, By Technology
      • 8.4.7.3. Market Size and Forecast, By Specimen
      • 8.4.7.4. Market Size and Forecast, By End User
    • 8.4.8. Japan Immunoassay Market
      • 8.4.8.1. Market Size and Forecast, By Product
      • 8.4.8.2. Market Size and Forecast, By Technology
      • 8.4.8.3. Market Size and Forecast, By Specimen
      • 8.4.8.4. Market Size and Forecast, By End User
    • 8.4.9. India Immunoassay Market
      • 8.4.9.1. Market Size and Forecast, By Product
      • 8.4.9.2. Market Size and Forecast, By Technology
      • 8.4.9.3. Market Size and Forecast, By Specimen
      • 8.4.9.4. Market Size and Forecast, By End User
    • 8.4.10. South Korea Immunoassay Market
      • 8.4.10.1. Market Size and Forecast, By Product
      • 8.4.10.2. Market Size and Forecast, By Technology
      • 8.4.10.3. Market Size and Forecast, By Specimen
      • 8.4.10.4. Market Size and Forecast, By End User
    • 8.4.11. Australia Immunoassay Market
      • 8.4.11.1. Market Size and Forecast, By Product
      • 8.4.11.2. Market Size and Forecast, By Technology
      • 8.4.11.3. Market Size and Forecast, By Specimen
      • 8.4.11.4. Market Size and Forecast, By End User
    • 8.4.12. Rest of Asia-Pacific Immunoassay Market
      • 8.4.12.1. Market Size and Forecast, By Product
      • 8.4.12.2. Market Size and Forecast, By Technology
      • 8.4.12.3. Market Size and Forecast, By Specimen
      • 8.4.12.4. Market Size and Forecast, By End User
  • 8.5. LAMEA
    • 8.5.1. Key Market Trends and Opportunities
    • 8.5.2. Market Size and Forecast, By Product
    • 8.5.3. Market Size and Forecast, By Technology
    • 8.5.4. Market Size and Forecast, By Specimen
    • 8.5.5. Market Size and Forecast, By End User
    • 8.5.6. Market Size and Forecast, By Country
    • 8.5.7. Brazil Immunoassay Market
      • 8.5.7.1. Market Size and Forecast, By Product
      • 8.5.7.2. Market Size and Forecast, By Technology
      • 8.5.7.3. Market Size and Forecast, By Specimen
      • 8.5.7.4. Market Size and Forecast, By End User
    • 8.5.8. South Africa Immunoassay Market
      • 8.5.8.1. Market Size and Forecast, By Product
      • 8.5.8.2. Market Size and Forecast, By Technology
      • 8.5.8.3. Market Size and Forecast, By Specimen
      • 8.5.8.4. Market Size and Forecast, By End User
    • 8.5.9. Saudi Arabia Immunoassay Market
      • 8.5.9.1. Market Size and Forecast, By Product
      • 8.5.9.2. Market Size and Forecast, By Technology
      • 8.5.9.3. Market Size and Forecast, By Specimen
      • 8.5.9.4. Market Size and Forecast, By End User
    • 8.5.10. Rest of LAMEA Immunoassay Market
      • 8.5.10.1. Market Size and Forecast, By Product
      • 8.5.10.2. Market Size and Forecast, By Technology
      • 8.5.10.3. Market Size and Forecast, By Specimen
      • 8.5.10.4. Market Size and Forecast, By End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top Winning Strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Top Player Positioning, 2023

CHAPTER 10: COMPANY PROFILES

  • 10.1. F. Hoffmann-La Roche Ltd.
    • 10.1.1. Company Overview
    • 10.1.2. Key Executives
    • 10.1.3. Company Snapshot
    • 10.1.4. Operating Business Segments
    • 10.1.5. Product Portfolio
    • 10.1.6. Business Performance
    • 10.1.7. Key Strategic Moves and Developments
  • 10.2. Danaher Corporation
    • 10.2.1. Company Overview
    • 10.2.2. Key Executives
    • 10.2.3. Company Snapshot
    • 10.2.4. Operating Business Segments
    • 10.2.5. Product Portfolio
    • 10.2.6. Business Performance
    • 10.2.7. Key Strategic Moves and Developments
  • 10.3. Abbott Laboratories
    • 10.3.1. Company Overview
    • 10.3.2. Key Executives
    • 10.3.3. Company Snapshot
    • 10.3.4. Operating Business Segments
    • 10.3.5. Product Portfolio
    • 10.3.6. Business Performance
    • 10.3.7. Key Strategic Moves and Developments
  • 10.4. Siemens Healthineers
    • 10.4.1. Company Overview
    • 10.4.2. Key Executives
    • 10.4.3. Company Snapshot
    • 10.4.4. Operating Business Segments
    • 10.4.5. Product Portfolio
    • 10.4.6. Business Performance
    • 10.4.7. Key Strategic Moves and Developments
  • 10.5. DiaSorin S.p.A.
    • 10.5.1. Company Overview
    • 10.5.2. Key Executives
    • 10.5.3. Company Snapshot
    • 10.5.4. Operating Business Segments
    • 10.5.5. Product Portfolio
    • 10.5.6. Business Performance
    • 10.5.7. Key Strategic Moves and Developments
  • 10.6. Sysmex Corporation
    • 10.6.1. Company Overview
    • 10.6.2. Key Executives
    • 10.6.3. Company Snapshot
    • 10.6.4. Operating Business Segments
    • 10.6.5. Product Portfolio
    • 10.6.6. Business Performance
    • 10.6.7. Key Strategic Moves and Developments
  • 10.7. BioMerieux SA
    • 10.7.1. Company Overview
    • 10.7.2. Key Executives
    • 10.7.3. Company Snapshot
    • 10.7.4. Operating Business Segments
    • 10.7.5. Product Portfolio
    • 10.7.6. Business Performance
    • 10.7.7. Key Strategic Moves and Developments
  • 10.8. Ortho Clinical Diagnostics
    • 10.8.1. Company Overview
    • 10.8.2. Key Executives
    • 10.8.3. Company Snapshot
    • 10.8.4. Operating Business Segments
    • 10.8.5. Product Portfolio
    • 10.8.6. Business Performance
    • 10.8.7. Key Strategic Moves and Developments
  • 10.9. Thermo Fisher Scientific, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Key Executives
    • 10.9.3. Company Snapshot
    • 10.9.4. Operating Business Segments
    • 10.9.5. Product Portfolio
    • 10.9.6. Business Performance
    • 10.9.7. Key Strategic Moves and Developments
  • 10.10. Becton, Dickinson And Company
    • 10.10.1. Company Overview
    • 10.10.2. Key Executives
    • 10.10.3. Company Snapshot
    • 10.10.4. Operating Business Segments
    • 10.10.5. Product Portfolio
    • 10.10.6. Business Performance
    • 10.10.7. Key Strategic Moves and Developments
  • 10.11. Merck KGaA
    • 10.11.1. Company Overview
    • 10.11.2. Key Executives
    • 10.11.3. Company Snapshot
    • 10.11.4. Operating Business Segments
    • 10.11.5. Product Portfolio
    • 10.11.6. Business Performance
    • 10.11.7. Key Strategic Moves and Developments